Project Portfolio
Our portfolio comprises four areas – technology platforms, biotechnology and therapies, medical technology, and artificial intelligence. Co-investors benefit from our strong focus and diversified risk profile.
Artifical Intelligence
The artificial intelligence/digital medicine segmentdeals with the deployment of AI to improvediagnostic methods and/or to improve processesin the field of biotechnology.
Project stages 2024
XLIFE
R&D
POC
EXIT
FUSE-AI
Companies
FUSE-AI GmbH is an e-health company that aims to improve medical care with intelligent software solutions, i.e., AI-supported software, for radiology.
FUSE-AI GmbH is a Hamburg-based e-health company founded in 2017 with the goal of improving medical care with intelligent software solutions, i.e., AI-supported software for radiology. The AI algorithm "prostate.Carcinoma.ai" analyzes a large number of radiological images in a very short time with a lower error rate than the human eye. The algorithm is designed to be applicable to other areas of image recognition, even outside the medical field.
Incorporation
2017
Location
Hamburg, Germany
